Feng Liu

3PUBLICATIONS
73CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Apr 17, 2025
First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer.

Timothy A Yap, Jonathan W Goldman, Shaveta Vinayak

|Mar 21, 2025
18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.

Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang

Pageof 1

Frequent Collaborators

2 joint publications

Todd VanArsdale

1 joint publications

Anand Giddabasappa

1 joint publications

Ziyue Karen Jiang

1 joint publications

Bing Yang